研究者
J-GLOBAL ID：202301016944603818
更新日: 2024年05月02日
増田 大作
マスダ ダイサク | Masuda Daisaku
所属機関・部署：
職名：
センター長
競争的資金等の研究課題 (3件)：
- 2015 - 2018 カイロミクロンレムナント蓄積の臨床的意義とリポ蛋白単離による機能解析
- 2012 - 2015 新規HDL結合蛋白プログラニュリンは全身性炎症・糖代謝異常・動脈硬化を抑制する
- 2011 - 2012 脂肪酸トランスポーターCD36の欠損マウスを用いた心筋症の発症機序の解明
論文 (93件)：
-
Shunsuke Tamaki, Yohei Sotomi, Yoshiyuki Nagai, Ryu Shutta, Daisaku Masuda, Nobuhiko Makino, Shizuya Yamashita, Masahiro Seo, Takahisa Yamada, Akito Nakagawa, et al. Relationship of interleukin-16 with different phenogroups in acute heart failure with preserved ejection fraction. ESC heart failure. 2024
-
Yasuaki Takeji, Hayato Tada, Masatsune Ogura, Atsushi Nohara, Masa-aki Kawashiri, Shizuya Yamashita, Mariko Harada-Shiba, Mariko Harada-Shiba, Shun Ishibashi, Shinji Yokoyama, et al. Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan. JACC: Asia. 2023
-
Shizuya Yamashita, Manfredi Rizzo, Ta-Chen Su, Daisaku Masuda. Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis. Metabolites. 2023. 13. 5
-
Kento Hosomi, Hidekazu Kawashima, Atsushi Nakano, Akemi Kakino, Yuko Okamatsu-Ogura, Yuki Yamashita, Mai Sasaoka, Daisaku Masuda, Shizuya Yamashita, Chu-Huang Chen, et al. NanoSPECT imaging reveals the uptake of 123I-labelled oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36. Cardiovascular research. 2023. 119. 4. 1008-1020
-
Daisaku Masuda. Triglyceride Level and Cardiovascular Risk Reduction Using Pemafibrate Compared with Fibrates. Journal of atherosclerosis and thrombosis. 2023. 30. 5. 429-431
もっと見る
MISC (29件)：
-
Shunsuke Tamaki, Yoshiyuki Nagai, Ryu Shutta, Daisaku Masuda, Ryosuke Murai, Shohei Yoshima, Makoto Abe, Koji Sako, Shizuya Yamashita, Masahiro Seo, et al. The Combination of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Acute Decompensated Heart Failure Patients With Preserved Left Ventricular Ejection Fraction: A Multicenter Study. CIRCULATION. 2021. 144
-
Shizuya Yamashita, Mitsuyo Okazaki, Takeshi Okada, Daisaku Masuda, Hidenori Arai, Koutaro Yokote, Eiichi Araki, Shun Ishibashi. Differences in Lipoprotein Particle Number Evaluation Between Gel Permeation-High Performance Chromatography and Nuclear Magnetic Resonance: Analysis in Dyslipidemic Patients Treated With a Selective Peroxisome Prolifetator-Activated Receptor a Modulator, Pemafibrate. CIRCULATION. 2019. 140
-
Takeshi Okada, Tohru Ohama, Kotaro Kanno, Hibiki Matsuda, Masami Sairyo, Yinghong Zhu, Ayami Saga, Takuya Kobayashi, Daisaku Masuda, Masahiro Koseki, et al. SHOTGUN PROTEOMICS ANALYSIS CHARACTERIZES HDL PROTEOME IN PATIENTS WITH CHOLESTERYL ESTER TRANSFER PROTEIN DEFICIENCY. ATHEROSCLEROSIS. 2017. 263. E3-E4
-
Takeshi Okada, Tohru Ohama, Mizuki Sumida, Yuki Katayama, Kotaro Kanno, Hibiki Matsuda, Masami Sairyo, Yinghong Zhu, Ayami Saga, Takuya Kobayashi, et al. DEVELOPMENT OF ENZYME-LINKED IMMUNOSORBENT ASSAY FOR OXIDIZED HIGH DENSITY LIPOPROTEIN AND ITS CLINICAL APPLICATION FOR CARDIOVASCULAR RISK ASSESSMENT. ATHEROSCLEROSIS. 2017. 263. E96-E96
-
Masuda Daisaku, Takuya Kobayashi, Masami Sairyo, Takeshi Okada, Masahiro Koseki, Tohru Ohama, Makoto Nishida, Yasushi Sakata, Shizuya Yamashita. ANALYSIS OF SELECTIVELY ISOLATED CHYLOMICRON REMNANTS IN VARIOUS CONDITIONS. ATHEROSCLEROSIS. 2017. 263. E210-E210
もっと見る
前のページに戻る
